Fermented food products in the era of globalization: tradition meets biotechnology innovations

Fermented food products in the era of globalization: tradition meets biotechnology innovations

Omics tools offer the opportunity to characterize and track traditional food and industrial fermentation. Bioinformatics, through machine learning, and other advanced statistical approaches, able to parse the fermentation process and predict the evolution and metabolic yields of food microbial ecosystems. By assembling a microbial-made consortival, the progress of biotechnology will also be able to increase the nutritional value and organoleptic characteristics of fermented food, preserve, at the same time, the potential of microbial consortiums autochthonous and metabolic pathways, which are difficult to reproduce. Preserving traditional methods contribute to protecting hidden values ​​from local biodiversity, and exploiting their potential in industrial processes with the final objectives guaranteeing food security and safety, even in developing countries.

Biotechnology and therapeutic-based therapeutial strategies for age-related macular degeneration. Part I: Biomaterial-based drug delivery device

The age-related macular degeneration (AMD) is a chronic neurodegenerative eye disease that can be treated in the latest, and the main causes of blindness in more than 65 years. It is characterized by slow developments and the existence of many factors, highlights associated with diet, genetic inheritance and environmental conditions, present at each stage of the disease. The current therapeutic approach, mainly consists of administration of intraocular drugs, only used to eliminate symptoms and / or to exceed the development of the disease.

Furthermore, they are too simple and ignore the complexity of the disease and large differences in the symptomatology between patients. Due to the broad impact of AMD and the absence of current clinical solutions, the development of a biomaterial-based approach for subjective and controlled therapeutic and biomolecular delivery represents the main challenges for the defeat of neurodegenerative diseases.

Here we present a critical review of the AMD therapy approach that is available and in development, from biomaterials and biotechnology perspectives. We highlight the benefits and limitations and we estimate the upcoming alternatives based on new biomaterials and biotechnology methods. In the first part we expose the physiological and clinical aspects of the disease, focusing on several factors that gave the origin of interference and highlight the contribution of these factors to the trigger of every step of the disease. Then we analyze available and in the development of biomaterial-based drug delivery devices (DDD), taking into account the characteristics of anatomy and functional from a healthy and sick retinal tissue.

RCSB Protein Data Banks: Strong new tools to explore biological 3D macromolecular structures for basic and applied research and applied in fundamental biology, biomedical, biotechnology, bioengineering and energy science

Collaboratory Research for Bioinformatics Structural Protein Data Bank (RCSB GDP), US Data Center for Global GDP Archives and Founder Members of the World Worldwide Protein Data Partners, serving tens of thousands of data deposits in America and Oceania and making 3D macromolecular structure data available at no cost and without Limitations to millions of users of RCSB.org worldwide, including> 660,000 educators, students and community members who want to know using pdb101.rcsb.org.

PDB data deposits include structural biologists using macromolecular crystallography, nuclear magnetic resonance spectroscopy, 3D electron microscope and micro-electron diffraction. Consumer GDP data that accesses our web portals includes researchers, educators and students who study fundamental biology, biomedical, biotechnology, bioengineering and energy science. Over the past 2 years, the RCSB GDP web portal which focuses on research (RCSB.org) has experienced a complete redesign, allowing increased searches with full Boolean operator logic and easier access to integrated GDP data with> 40 external biodata resources. New features and resources are explained in detail using examples that show the structure of SARS-COV-2 protein which was recently released and host cell protein relevant to understanding and overcoming Global Pandemics Covid-19.

Holistic Approach Banking Cell NGNokan Swiss Fetus: Optimizing Safe and Sustainable Substrate for Regenerative Treatment and Biotechnology

The iterative safety, quality and optimization driven by the selection of therapeutic cell sources has formed the basic rock in the core development for primary fetal progenitor cell therapy (FPC) in Switzerland for three decades. Pragmatic adjustable fetus transplant program is designed as a direct workflow for network procurement, maximizing traceability, safety, consistency, and robustness of cultured progeni cellular materials. The standardization of intact cell bioprocess has provided adequate insight into adequate conjugation of modern biotechnology progress with the current legislative, ethical and regulatory framework.

Fermented food products in the era of globalization: tradition meets biotechnology innovations

Pioneer translational progress in regenerative skin and musculoskeletal treatment continuously shows the potential for FPC therapy. Extensive technical and clinical actions were collected by managing pediatric burns and geriatric ulcers in Switzerland. The simultaneous industrial transposition of Dermal FPC banks, after good manufacturing practice, shows the wide potential of their therapeutic value. Furthermore, in Extenso, the exponential revalorization of Swiss FPC technology can be achieved through an integrative update of the model framework. Consideration of longitudinal and transverse aspects of simultaneous fetal network differential processing allows a better understanding of potential power expansion – unlimited in multi-tiered main FPC banks.

NH4 Buffer, 10x

BIO-37025 3 x 1.2ml Ask for price

10X TAE Buffer

T8048-101 1L
EUR 89

TBS Buffer, 10X

T8057-100 1L
EUR 115

TBS Buffer, 10X

T8057-105 5x1L
EUR 286

HEK293-TetR (Neo)

SC005-Neo 2 x 106 cell/ml x 1ml
EUR 1210
Description: tetracycline repressor in HEK293 stable cell line with Neomycin fusion marker

Blocking Buffer, 10X, 250ML

X109-250ML 250ML
EUR 359

Blocking Buffer, 10X, 25ML

X109-25ML 25ML
EUR 122

25ML 10X CE Buffer

NAT1206 25ML
EUR 115

100ML 10X CE Buffer

NAT1208 100ML
EUR 164

10x TAE Buffer Solution

BA01801 6x100ml
EUR 97
Description: High purity buffer for various PCR applications.

10x PBS Buffer Solution

BA01802 6x100ml
EUR 97
Description: High purity buffer for various PCR applications.

10x TBE Buffer Solution

BA01804 6x100ml
EUR 97
Description: High purity buffer for various PCR applications.

10X TAE buffer solution

A00239 500ml
EUR 56.36

10x Gel Loading Buffer

TG4038 1ml
EUR 156

10X KRB-IBMX Buffer

122937 1 Vial
EUR 77

Binding/Coating Buffer (10X)

85R-124 250 ml
EUR 216
Description: ELISA buffer for optimal coating and binding of antibodies and antigens

Alkaline Phosphate Buffer, 10x

K2191050-6 50 ml
EUR 137
Description: Can be used for various proteomics studies in both normal and pathological cases. It is an excellent control and suitable for educational purposes. This product is prepared from whole tissue homogenates and has undergone SDS-PAGE quality control analysis. The protein is stored in a buffer with protease inhibitor cocktail fo prevent degradation.

hTERT (CMV, Neo) lentivirus

LVP1130-Neo 1x107 IFU/ml x 200ul
EUR 349
Description: Premade lentivirus expressing human TERT gene under suCMV promoter, containing Neomycin marker.

hTERT (EF1a, Neo) lentivirus

LVP1131-Neo 1x107 IFU/ml x 200ul
EUR 349
Description: Premade lentivirus expressing human TERT gene under EF1a promoter, containing Neomycin marker.

rtTA (Neo) , Lentiviral particles

LVP400-Neo 1x107 IFU/ml x 200ul
EUR 404
Description: Pre-made lentiviral particles expressing reverse tetracycline Transcriptional Activator (rtTA) under enhanced EF1a promoter with Neomycin antibioic marker, provided in DMEM medium with 10% FBS.

10X Tris-Glycine Native Buffer (Transfer buffer)

T8052-050 500ml
EUR 80

10X Tris-Glycine Native Buffer (Transfer buffer)

T8052-100 2X500ml
EUR 104

10X Tris-Glycine Native Buffer (Transfer buffer)

T8052-101 1L
EUR 95

10X Tris-Glycine Native Buffer (Transfer buffer)

T8052-200 4X500ml
EUR 128

10X Tris-Glycine Native Buffer (Transfer buffer)

T8052-201 2X1L
EUR 128

10X Tris-Glycine Native Buffer (Transfer buffer)

T8052-401 4X1L
EUR 165

CMV-TetR (Neo) Lentiviral particles 

LVP017-Neo 1x107 IFU/ml x 200ul
EUR 404
Description: Pre-made lentiviral particles expressing tetracycline regulator protein (TetR) under CMV promoter, with Neomycin antibiotic marker.

β-Lactamase (Neo) lentiviral particles

LVP335-Neo 1x107 IFU/ml x 200ul
EUR 349
Description: pre-made lentiviral particles expressing β-Lactamase gene. A Neomycin marker was expressed under RSV promoter. Particles is provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

EF1a-TetR (Neo) Lentiviral particles 

LVP459-Neo 1x107 IFU/ml x 200ul
EUR 404
Description: Pre-made lentiviral particles expressing tetracycline regulator protein (TetR) under enhanced EF1a promoter with Neomycin antibioic marker.

PBST buffer 10x Strength Solution

PW004 500ml
EUR 67.4

TBST buffer 10x Strength Solution

PW009 500ml
EUR 65.66

Annexin V Binding Buffer (10x)

EXB0019 N/A
EUR 86

SuperBlot Western Transfer buffer 10X

DG-WEST 500ml
EUR 113.8

10X PBS Buffer , pH 7.4

P2100-050 500ml
EUR 88

10X PBS Buffer , pH 7.4

P2100-100 1L
EUR 91

Xpert Native Transfer Buffer(10X)

P9001-050 500ml
EUR 93

Xpert Native Transfer Buffer(10X)

P9001-100 1L
EUR 138

10x Tris-Glycine Buffer Solution

BA01806 6x100ml
EUR 97
Description: High purity buffer for various PCR applications.

1 L TAE BUFFER, 10X

46-010-CM 1L/pk
EUR 105
Description: Media Catalog; Classical Media

Aniline, 10X in acetate buffer

91057 10ML
EUR 111
Description: Minimum order quantity: 1 unit of 10ML

10X Tris-Glycine SDS buffer

T8053-050 500ml
EUR 85

10X Tris-Glycine SDS buffer

T8053-100 2X500ml
EUR 111

10X Tris-Glycine SDS buffer

T8053-101 1L
EUR 99

10X Tris-Glycine SDS buffer

T8053-104 4 L
EUR 153

10X Tris-Glycine SDS buffer

T8053-200 4X500ml
EUR 136

10X Tris-Glycine SDS buffer

T8053-201 2X1L
EUR 135

10X Tris-Glycine SDS buffer

T8053-401 4X1L
EUR 172

TBS Buffer, 10X , Refill Pack

T8057-401 1 Gal
EUR 182

Topo I Assay Buffer 10x

TG4010 1ml
EUR 145

West-Ezier Washing Buffer(10X)

W3873-050 500ml
EUR 118

Citrate Buffer (10x) pH 6.0

CBB125 125 ml
EUR 66

Citrate Buffer (10x) pH 6.0

CBB500 500 ml
EUR 80

Citrate Buffer (10x) pH 6.0

CBB999 1000 ml
EUR 98

Colloidal Gold Running Buffer (10X)

CG-RB10 10 ml
EUR 225

Dilution buffer R (10x); ELISPOT

CT348 10 ml
EUR 78

Dilution buffer T (10x); ELISPOT

CT358 8 ml
EUR 78

10x PCR Buffer without MgCl2

ABP-PP-ERBF001 1x1ml Ask for price

10x PCR Buffer without MgCl2

ABP-PP-ERBF002 2x1ml Ask for price

10x PCR Buffer without MgCl2

ABP-PP-ERBF005 5x1ml Ask for price

10x PCR Buffer with MgCl2

ABP-PP-ERBFM01 1x1ml Ask for price

10x PCR Buffer with MgCl2

ABP-PP-ERBFM02 2x1ml Ask for price

10x PCR Buffer with MgCl2

ABP-PP-ERBFM05 5x1ml Ask for price

EIA Wash Buffer 10x concentrate

1003-1 1 Liter
EUR 231

10X Annexin V Binding Buffer

1006-100
EUR 196

LoxP GFP/RFP ColorSwitch (Neo) lentivirus

LVP460-Neo 1x107 IFU/ml x 200ul
EUR 710
Description: Pre-made lentiviral particles expressing "LoxP-GFP-stop-LoxP-RFP-Stop" cassette under suCMV promoter. It also contains a Neomycin antibiotic selection marker under Rsv promoter. Virus is provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

amfiEco Taq Reaction Buffer(2X)

P0703-001 1ml
EUR 84

amfiEco Taq Reaction Buffer(2X)

P0703-005 5ml
EUR 178

pWZL-Neo Retroviral Vector

RTV-001-NEO 10 ?g
EUR 566
Description: Use this construct to clone your gene for downstream recombinant retroviral packaging

SV40 large T-antigen (Neo), CMV lentiviral particles

LVP016-Neo 1x107 IFU/ml x 200ul
EUR 349
Description: Pre-made lentiviral particles expressing SV40 large T-antigen under suCMV promoter, containing Neomycin marker.

SV40 large T-antigen (Neo), EF1a lentiviral particles

LVP557-Neo 1x107 IFU/ml x 200ul
EUR 349
Description: Pre-made lentiviral particles expressing SV40 large T-antigen under EF1a promoter, containing Neomycin marker.

Finegel SDS-PAGE Running Buffer(10X)

F1504-050 500ml
EUR 151

Finegel SDS-PAGE Running Buffer(10X)

F1504-100 2x500ml
EUR 201

1L Tris-Glycine Electroblotting Buffer 10X

NAT1240 1L
EUR 85

4L Tris-Glycine Electroblotting Buffer 10X

NAT1242 4L
EUR 121

TG Buffer (Tris-Glycine) 10X Solution

UA0028 500ml
EUR 59.4

10X ELISA Wash Buffer (125 mL)

0801060 125 mL
EUR 65.6
Description: Please contact Gentaur in order to receive the datasheet of the product.

10x Tris-Glycine-SDS Buffer Solution

BA01807 6x100ml
EUR 103
Description: High purity buffer for various PCR applications.

TG Buffer (TRIS-GLYCINE) 10X Solution

A0028 4L
EUR 94.8

1 L TBE BUFFER, 10X, LIQUID

46-011-CM 1L/pk
EUR 118
Description: Media Catalog; Classical Media

T-Pro Transfer Blotting buffer (10X)

JB08-H001 500ml/BT
EUR 135

Dilution buffer B (10x); ELISPOT (PVDF)

CT364 8 ml
EUR 78

10X Red Blood Cell Lysis Buffer

5831-100
EUR 120

EF1a Control lentiviral particles (Neo)

EF1a-Null-Neo 1 x107 IFU/ml x 200ul
EUR 349
Description: Negative control lentivirus contains a null spacer insert under EF1a promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It also has the Neomycin marker under RSV promoter.

CMV Control lentiviral particles (Neo)

CMV-Null-Neo 1 x107 IFU/ml x 200ul
EUR 349
Description: Negative control lentivirus contains a null spacer insert under CMV promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It also has the Neomycin marker under RSV promoter.

amfiXpand Taq DNA Ploymerase Buffer*(2X)

P0332-001 1ml
EUR 101

Taq DNA Polymerase (Mg2+ plus Buffer)

P101-01 1000 U
EUR 121

Taq DNA Polymerase (Mg2+ plus Buffer)

P101-02 5000 U
EUR 193

Taq DNA Polymerase (Mg2+ plus Buffer)

P101-03 10000 U
EUR 262

Taq DNA Polymerase (Mg2+ free Buffer)

P102-01 1000 U
EUR 121

Taq DNA Polymerase (Mg2+ free Buffer)

P102-02 5000 U
EUR 193

Taq DNA Polymerase (Mg2+ free Buffer)

P102-03 10000 U
EUR 262

hTERT (CMV, Neo) lentivirus in PBS

LVP1130-Neo-PBS 1x108 IFU/ml x 200ul
EUR 710
Description: Concentrated lentivirus in PBS, expressing human TERT gene under suCMV promoter, containing Neomycin marker.

hTERT (EF1a, Neo) lentivirus in PBS

LVP1131-Neo-PBS 1x108 IFU/ml x 200ul
EUR 710
Description: Concentrated lentivirus in PBS, expressing human TERT gene under EF1a promoter, containing Neomycin marker.

rtTA (Neo) in PBS, Lentiviral particles

LVP400-Neo-PBS 5x107 IFU/ml x 200ul
EUR 507
Description: Pre-made lentiviral particles expressing reverse tetracycline Transcriptional Activator (rtTA) under enhanced EF1a promoter with Neomycin antibioic marker, concentrated particles provided in PBS solution.

1L Tris-Tricine-SDS PAGE Buffer (10X)

NAT1214 1L
EUR 181

1L Tris-Glycine-SDS PAGE Buffer (10X)

NAT1216 1L
EUR 88

4L Tris-Glycine-SDS PAGE Buffer (10X)

NAT1218 4L
EUR 124

10X PBS Buffer , pH 7.4, Refill Pack

P2100-204 3.5L
EUR 138

10X PBS Buffer , pH 7.4, Refill Pack

P2100-208 8L
EUR 219

Xpert SDS-PAGE Gel Running Buffer(10X)

P9000-050 500ml
EUR 97

Xpert SDS-PAGE Gel Running Buffer(10X)

P9000-100 1L
EUR 138

Xpert Native Transfer Buffer(10X), Refill Pack

P9001-204 3.5 L
EUR 219

TBS buffer (Tris-Buffered Saline), 10x Solution

UA00279 500ml
EUR 58.48

TE Buffer (Tris-EDTA), 10X, pH 7.4

USD8211 500ml
EUR 64.36

TBE buffer (Tris-Borate-EDTA), 10x Solution

A0026 4L
EUR 93.93

TBS buffer (Tris-Buffered Saline), 10x Solution

A0027 4L
EUR 93.93

EDTA - Saline Buffer (10X Concentrate); pH 8.0

ETA010 10 L
EUR 633

EDTA - Saline Buffer (10X Concentrate); pH 8.0

ETA500 500 ml
EUR 98

EDTA - Saline Buffer (10X Concentrate); pH 8.0

ETA999 1000 ml
EUR 119

Color Switch, CRE report cell line: HEK293-loxP-GFP-RFP Neo)

SC018-Neo 2x10E6 cell/ml x1ml
EUR 4400
Description: CRE reporter cell line (Neo): HEK293 cell line expressing "LoxP-GFP-stop-LoxP-RFP" cassette with Neomycin antibiotic marker

HotStart Taq DNA Polymerase (Mg2+ Plus Buffer)

RK20601 25 U Ask for price

CMV-TetR (Neo) Lentiviral particles  in PBS

LVP017-Neo-PBS 5x107 IFU/ml x 200ul
EUR 507
Description: Pre-made lentiviral particles expressing tetracycline regulator protein (TetR) under CMV promoter, with Neomycin antibiotic marker. Particles pellet was re-suspended in PBS solution.

EF1a-TetR (Neo) Lentiviral particles  in PBS

LVP459-Neo-PBS 5x107 IFU/ml x 200ul
EUR 507
Description: Pre-made lentiviral particles expressing tetracycline regulator protein (TetR) under enhanced EF1a promoter with Neomycin antibioic marker. Particles was pellet down and re-suspended in PBS solution.

LoxP GFP/RFP ColorSwitch (Neo) lentivirus (concentrated)

LVP460-Neo-PBS 5x107 IFU/ml x 200ul
EUR 862
Description: Pre-made lentiviral particles expressing "LoxP-GFP-stop-LoxP-RFP-Stop" cassette under suCMV promoter. It also contains a Neomycin antibiotic selection marker under Rsv promoter. Virus was provied in PBS solution.

Citrate Buffer(10X), pH 6.0 for Antigen Retriever

C7915-010 100ml
EUR 112

Citrate Buffer(10X), pH 6.0 for Antigen Retriever

C7915-050 500ml
EUR 199

ELISA Plate Coating buffer concentrate pH 7.4 (10X)

80050 50 ml
EUR 164

ELISA Plate Coating buffer concentrate pH 9.6 (10X)

80051 50 ml
EUR 164

ELISA Plate Blocking Buffer concentrate (10X) BSA-based

80060 50 ml
EUR 202

ELISA Plate Blocking Buffer concentrate (10X) milk-based

80062 100 ml
EUR 202

Western blot recycling stripping buffer, 50 ml (10X)

90101 50 ml
EUR 238

TG-SDS Buffer (Tris-Glycine-SDS) 10X Solution

A0030 4L
EUR 94.8

3-D Life 10x CB-Buffer (pH 5.5)

B10-3 600 µl
EUR 44

3-D Life 10x CB Buffer (pH 7.2)

B20-3 600 µL
EUR 44

T-Pro Tris-Glycine-SDS running buffer (10X)

JB07-G001 500ml/BT
EUR 135

T-Pro Tris-Glycine-Native running buffer (10X)

JB07-G002 500ml/BT
EUR 135

T-Pro Semi Dry Transfer Blotting buffer (10X)

JB08-H002 500ml/BT
EUR 144

Taq DNA Polymerase (Mg2+ plus Buffer, with dNTP)

P101-d1 1000 U
EUR 136

Taq DNA Polymerase (Mg2+ plus Buffer, with dNTP)

P101-d2 5000 U
EUR 267

Taq DNA Polymerase (Mg2+ plus Buffer, with dNTP)

P101-d3 10000 U
EUR 409

Taq DNA Polymerase (Mg2+ free Buffer, with dNTP)

P102-d1 1000 U
EUR 136

Taq DNA Polymerase (Mg2+ free Buffer, with dNTP)

P102-d2 5000 U
EUR 267

Taq DNA Polymerase (Mg2+ free Buffer, with dNTP)

P102-d3 10000 U
EUR 409

SV40 large T-antigen (Neo) in PBS, CMV lentiviral particles

LVP016-Neo-PBS 5x107 IFU/ml x 200ul
EUR 710
Description: Pre-made lentiviral particles expressing SV40 large T-antigen under suCMV promoter, containing Neomycin marker, provided in PBS solution.

SV40 large T-antigen (Neo) in PBS, EF1a lentiviral particles

LVP557-Neo-PBS 5x107 IFU/ml x 200ul
EUR 710
Description: Pre-made lentiviral particles expressing SV40 large T-antigen under EF1a promoter, containing Neomycin marker, provided in PBS solution.

EF1a Control lentiviral particles (Neo) in PBS

EF1a-Null-Neo-PBS 1 x108 IFU/ml x 200ul
EUR 710
Description: Negative control lentivirus contains a null spacer insert under EF1a promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It also has the Neomycin marker under RSV promoter. The virus was concentrated and provided in PBS solution.

CMV Control lentiviral particles (Neo) in PBS

CMV-Null-Neo-PBS 1 x108 IFU/ml x 200ul
EUR 710
Description: Negative control lentivirus contains a null spacer insert under CMV promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It also has the Neomycin marker under RSV promoter. The virus was concentrated and provided in PBS solution.

Xpert SDS-PAGE Gel Running Buffer(10X), Refill Pack

P9000-204 3.5 L
EUR 219

TG Buffer (TRIS-GLYCINE) 10x Premix powder - 1PK(4L)

A0029 4L
EUR 67.4

Tris-EDTA buffer (TE) 10x pH 7.4, 1000 ml

12-9154-10 1000 ml
EUR 174

ELISA Plate Blocking Buffer concentrate (10X) Gelatin-based (translucent formulation)

80061 100 ml
EUR 202

ELISA Plate Blocking Buffer concentrate (10X) milk-based (translucent formulation)

80063 100 ml
EUR 202

Tris-Borate-EDTA buffer (TBE) 10x pH 8.3, 1000 ml

12-9112-10 1000 ml
EUR 215

T-Pro Washing buffer in PBS and Tween-20 (10X)

JB09-I003 500ml/BT
EUR 144

Some fetal tissues (eg, skin, cartilage, tendons, muscles, bones, lungs) can be harvested simultaneously and processed for obedient cell culture, set a unique model for sustainable therapeutic cellular supply chains. Here, we integrate fundamental, preclinical, clinical, and industrial developments to realize scientific progress supported by the Swiss FPC Banking and we focus on progress made for the date of FPC which can be derived from a single organ donation. The new single model of bioprocessing donation is proposed, achieving sustainable standards and potential production of billions of therapeutic doses that are affordable and efficient.

Leave a Comment

Your email address will not be published.